Zobrazeno 1 - 4
of 4
pro vyhledávání: '"J'Aimee A. Louis"'
Autor:
Moon S. Chen, Ify Sargeant, Marianne Gandee, Nicole Richie, Julie H.T. Dang, Christopher Reddick, J'Aimee A. Louis, Homer Adams, Jovonni Spinner, Kenneth Turner, Rayneisha Watson, Quita Highsmith, Coleman K. Obasaju, Madeline Geday, Evelyn Gonzalez, Lola Fashoyin-Aje, Spencer C. Hoover, Jeanne M. Regnante, Simon J. Craddock Lee, Laura Lee Hall, Erin Fenske Williams
Publikováno v:
Contemporary Clinical Trials Communications
Contemporary Clinical Trials Communications, Vol 17, Iss, Pp-(2020)
Contemporary Clinical Trials Communications, Vol 17, Iss, Pp-(2020)
Background: Study populations in clinical research must reflect US changing demographics, especially with the rise of precision medicine. However, racial and ethnic minority groups (REMGs) have low rates of participation in cancer clinical trials. Me
Autor:
Gregory A. Hood, Grace Libby Campbell, Laura Lee Hall, Joseph Weigel, J'Aimee A. Louis, William B. Miller
Publikováno v:
Journal of Clinical Oncology. 37:164-164
164 Background: Kentucky is the epicenter of smoking and lung cancer in the U.S.: over half the population is a current or former smoker (second only to WV); and it has the highest annual lung cancer incidence—89.6 per 100,000 population—accordin
Autor:
Ify Sargeant, Simon J. Craddock Lee, Homer Adams, Spencer C. Hoover, Rayneisha Watson, Jeanne M. Regnante, Moon S. Chen, Coleman K. Obasaju, Nicole Richie, Marianne Gandee, Kenneth Turner, Lola Fashoyin-Aje, J'Aimee A. Louis, Madeline Geday, Quita Highsmith, Erin L Williams, Laura Lee Hall
Publikováno v:
Cancer Research. 79:LB-012
Background: Racial and ethnic minority groups (REMGs) have low rates of inclusion in cancer trials. With the rise of precision medicine, it is critical that study populations in clinical research reflect the changing US demographics. Methods: Criteri
Autor:
Lola Fashoyin-Aje, Quita Highsmith, Coleman K. Obasaju, Michelle Vichnin, Simon J. Craddock Lee, Marvella E. Ford, Nicole Richie, Julie H.T. Dang, Luther T. Clark, Spencer C. Hoover, Evelyn Gonzalez, Jeanne M. Regnante, Nestor F. Esnaola, Gail Larkins, Erin Fenske Williams, J'Aimee A. Louis, Laura Lee Hall, Daniel G. Petereit, Lorna H. McNeill
Publikováno v:
Journal of Clinical Oncology. 36:e18643-e18643
e18643Background: By 2050, racial and ethnic minorities (REMs) will constitute > 50% of the US population. Despite a high prevalence of certain cancers in REM populations, < 10% REMs diagnosed with...